She was treated with 20 mg intraarterial tPA at about 5 hr and 15 min after onset of symptoms, resulting in recanalization.
Pertinent Results: [**2108-2-1**] 11:30AM BLOOD WBC-5.3 RBC-4.05* Hgb-12.6 Hct-36.4 MCV-90 MCH-31.2 MCHC-34.8 RDW-12.7 Plt Ct-186 [**2108-2-1**] 11:30AM BLOOD PT-13.2 PTT-28.1 INR(PT)-1.1 [**2108-2-1**] 11:30AM BLOOD Glucose-81 UreaN-7 Creat-0.7 Na-140 K-4.0 Cl-109* HCO3-25 AnGap-10 [**2108-2-1**] 11:30AM BLOOD CK(CPK)-72 [**2108-2-2**] 02:00AM BLOOD CK(CPK)-60 [**2108-2-2**] 05:45AM BLOOD CK(CPK)-51 [**2108-2-1**] 11:30AM BLOOD CK-MB-NotDone cTropnT-<0.01 [**2108-2-2**] 02:00AM BLOOD CK-MB-NotDone cTropnT-<0.01 [**2108-2-2**] 05:45AM BLOOD CK-MB-NotDone cTropnT-<0.01 [**2108-2-1**] 11:30AM BLOOD Calcium-8.5 Phos-2.4* Cholest-172 [**2108-2-1**] 11:30AM BLOOD Triglyc-58 HDL-56 CHOL/HD-3.1 LDLcalc-104 [**2108-2-1**] 11:30AM BLOOD Fibrino-302 [**2108-2-1**] 11:30AM BLOOD ESR-12 [**2108-2-1**] 11:30AM BLOOD FacVIII-68 [**2108-2-1**] 11:30AM BLOOD Lupus-NEG AT III-PND Prot C-94 [**2108-2-1**] 11:30AM BLOOD [**Doctor First Name **]-NEGATIVE [**2108-2-1**] 11:30AM BLOOD RheuFac-4 CRP-0.53* [**2108-2-1**] 11:30AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG [**2108-2-1**] 11:30AM BLOOD ACTIVATED PROTEIN C -PND [**2108-2-1**] 11:30AM BLOOD PROTHROMBIN MUTATION ANALYSIS-PND [**2108-2-1**] 11:30AM BLOOD FACTOR V LEIDEN-PND [**2108-2-1**] 11:30AM BLOOD PROTEIN S,FUNCTIONAL-PND [**2108-2-1**] 11:30AM BLOOD CARDIOLIPIN ANTIBODY-PND ----- CT head [**2108-1-31**]: There is a small focus of intraparenchymal hemorrhage with associated moderate edema within the left occipital lobe.
There is also associated subdural hemorrhage along the left aspect of the tentorium cerebelli in this patient s/p cerebral angiogram with infusion of intra-arterial TPA.
----- Angiogram [**2108-1-31**]: Occlusion of a left P2 branch of the posterior cerebral artery with successful thrombolysis after infusion of approximately 20 mg of intraarterial TPA.
Bubble study is positive for right-to-left shunting at rest and with maneuvers.
She was treated initially with aspirin, and then was started on coumadin for anticoagulation after absence of intracerebral hemorrhage was confirmed.
Goal INR on coumadin is 2-2.5.
A hypercoagulable work-up was initiated, including studies for lupus anticoagulant, protein C and S deficiency, activate protein C mutation, antithrombin III mutation, factor V Leiden, and anticardiolipin antibody.
She was treated with iv fluids and encouraged to take more po fluid.
She will continue on coumadin and aspirin, and follow-up with Dr. [**First Name (STitle) **] [**Name (STitle) **] in Neurology at [**Hospital1 18**], at which time results of hypercoagulable work up will be reviewed in full.
She was treated transiently with Fiorecet and iv morphine.
By the time of discharge she required pain medications only once daily.
She was told that the pain medications are for short term use as prolonged use can cause tolerance to develop and lead to withdrawal symptoms.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for constipation.
Aspirin 325 mg Tablet, Delayed Release (E.C.)
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation.
Coumadin 5 mg Tablet Sig: One (1) Tablet PO at bedtime: Goal INR is [**12-22**].
Acetaminophen-Caff-Butalbital [**Medical Record Number 3668**] mg Tablet Sig: One (1) Tablet PO Q4-6H (every 4 to 6 hours) as needed.
Left PCA infarct status post IA tPA 2.
Please take all of your medications as directed.
Please bring all discharge paperwork including a medication list and discharge summary with you to this appointment.
